OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Neurofibromatosis Type 1 Implicates Ras Pathways in the Genetic Architecture of Neurodevelopmental Disorders
Jessica A. Kaczorowski, Taylor F. Smith, Amanda M. Shrewsbury, et al.
Behavior Genetics (2020) Vol. 50, Iss. 4, pp. 191-202
Open Access | Times Cited: 15
Jessica A. Kaczorowski, Taylor F. Smith, Amanda M. Shrewsbury, et al.
Behavior Genetics (2020) Vol. 50, Iss. 4, pp. 191-202
Open Access | Times Cited: 15
Showing 15 citing articles:
Allostery, and how to define and measure signal transduction
Ruth Nussinov, Chung‐Jung Tsai, Hyunbum Jang
Biophysical Chemistry (2022) Vol. 283, pp. 106766-106766
Open Access | Times Cited: 36
Ruth Nussinov, Chung‐Jung Tsai, Hyunbum Jang
Biophysical Chemistry (2022) Vol. 283, pp. 106766-106766
Open Access | Times Cited: 36
Roles of palmitoylation in structural long-term synaptic plasticity
Benjun Ji, Małgorzata Skup
Molecular Brain (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 39
Benjun Ji, Małgorzata Skup
Molecular Brain (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 39
Steady-state visual evoked potentials in children with neurofibromatosis type 1: associations with behavioral rating scales and impact of psychostimulant medication
Ève Lalancette, Audrey-Rose Charlebois-Poirier, Kristian Agbogba, et al.
Journal of Neurodevelopmental Disorders (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 10
Ève Lalancette, Audrey-Rose Charlebois-Poirier, Kristian Agbogba, et al.
Journal of Neurodevelopmental Disorders (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 10
Protein Phosphorylation Signaling Cascades in Autism: The Role of mTOR Pathway
И. С. Бокша, T. A. Prokhorova, Е. Б. Терешкина, et al.
Biochemistry (Moscow) (2021) Vol. 86, Iss. 5, pp. 577-596
Closed Access | Times Cited: 13
И. С. Бокша, T. A. Prokhorova, Е. Б. Терешкина, et al.
Biochemistry (Moscow) (2021) Vol. 86, Iss. 5, pp. 577-596
Closed Access | Times Cited: 13
A Targeted, Low-Throughput Compound Screen in aDrosophilaModel of Neurofibromatosis Type 1 Identifies Simvastatin and BMS-204352 as Potential Therapies for Autism Spectrum Disorder (ASD)
Alex Dyson, Megan Ryan, Shruti Garg, et al.
eNeuro (2023) Vol. 10, Iss. 5, pp. ENEURO.0461-22.2023
Open Access | Times Cited: 5
Alex Dyson, Megan Ryan, Shruti Garg, et al.
eNeuro (2023) Vol. 10, Iss. 5, pp. ENEURO.0461-22.2023
Open Access | Times Cited: 5
Early Developmental Signs in Children with Autism Spectrum Disorder: Results from the Japan Environment and Children’s Study
Hideki Shimomura, Hideki Hasunuma, Sachi Tokunaga, et al.
Children (2022) Vol. 9, Iss. 1, pp. 90-90
Open Access | Times Cited: 6
Hideki Shimomura, Hideki Hasunuma, Sachi Tokunaga, et al.
Children (2022) Vol. 9, Iss. 1, pp. 90-90
Open Access | Times Cited: 6
An executive functioning perspective in neurofibromatosis type 1: from ADHD and autism spectrum disorder to research domains
Taylor F. Smith, Jessica A. Kaczorowski, Maria T. Acosta
Child s Nervous System (2020) Vol. 36, Iss. 10, pp. 2321-2332
Closed Access | Times Cited: 7
Taylor F. Smith, Jessica A. Kaczorowski, Maria T. Acosta
Child s Nervous System (2020) Vol. 36, Iss. 10, pp. 2321-2332
Closed Access | Times Cited: 7
Assessing Psychiatric Comorbidity and Pharmacologic Treatment Patterns Among Patients With Neurofibromatosis Type 1
Alexander C Houpt, Shaina Schwartz, Robert A. Coover
Cureus (2021)
Open Access | Times Cited: 5
Alexander C Houpt, Shaina Schwartz, Robert A. Coover
Cureus (2021)
Open Access | Times Cited: 5
Time-frequency analyses of repetition suppression and change detection in children with neurofibromatosis type 1
Ève Lalancette, Audrey-Rose Charlebois-Poirier, Kristian Agbogba, et al.
Brain Research (2023) Vol. 1818, pp. 148512-148512
Closed Access | Times Cited: 1
Ève Lalancette, Audrey-Rose Charlebois-Poirier, Kristian Agbogba, et al.
Brain Research (2023) Vol. 1818, pp. 148512-148512
Closed Access | Times Cited: 1
A novel mutation of the NF1 gene in a Chinese family with neurofibromatosis type 1.
Qi He, Jingjing Jiang, Jiao Yang, et al.
PubMed (2022) Vol. 14, Iss. 7, pp. 5139-5145
Closed Access | Times Cited: 2
Qi He, Jingjing Jiang, Jiao Yang, et al.
PubMed (2022) Vol. 14, Iss. 7, pp. 5139-5145
Closed Access | Times Cited: 2
Introduction to the Special Issue on ‘The Genetic Architecture of Neurodevelopmental Disorders’
Mark J. Taylor, Tinca J. C. Polderman
Behavior Genetics (2020) Vol. 50, Iss. 4, pp. 185-190
Open Access | Times Cited: 2
Mark J. Taylor, Tinca J. C. Polderman
Behavior Genetics (2020) Vol. 50, Iss. 4, pp. 185-190
Open Access | Times Cited: 2
A targeted, low-throughput compound screen in aDrosophilamodel of neurofibromatosis type 1 identifies simvastatin and BMS-204352 as potential therapies for autism spectrum disorder (ASD)
Alex Dyson, Megan Ryan, Shruti Garg, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Alex Dyson, Megan Ryan, Shruti Garg, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Noncanonical structural requirements of neurofibromin SUMOylation reveal a folding-deficiency of several pathogenic mutants
Mohammed Bergoug, Christine Mosrin, Fabienne Godin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1
Mohammed Bergoug, Christine Mosrin, Fabienne Godin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1
Епидемиология на неврофиброматоза тип 1
Георги Стефанов, Елена Митова
Редки болести и лекарства сираци (2020) Vol. 11, Iss. 2, pp. 17-22
Open Access
Георги Стефанов, Елена Митова
Редки болести и лекарства сираци (2020) Vol. 11, Iss. 2, pp. 17-22
Open Access
Сигнальные каскады белкового фосфорилирования при аутизме (с акцентом на путь mTOR)
И. С. Бокша, T. A. Prokhorova, Е. Б. Терешкина, et al.
Биохимия (2021) Vol. 86, Iss. 5, pp. 643-666
Closed Access
И. С. Бокша, T. A. Prokhorova, Е. Б. Терешкина, et al.
Биохимия (2021) Vol. 86, Iss. 5, pp. 643-666
Closed Access
